ASTS
AST SpaceMobile, Inc.
ASTS offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
CEVA
CEVA, Inc.
CEVA has the edge over ASTS overall, supported by lower modeled downside.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CEVA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Strong |
CEVA's cash flow and balance sheet are currently healthy, and its revenue is stable, but its profitability is under pressure.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
CEVA PE Valuation
CEVA has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CEVA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CEVA, with profitability improving. However, they disagree widely on these estimates.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
CEVA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.74 | — |
| Q3 2026 | -$0.39 | +$0.07 |
| Q2 2026 | -$0.41 | +$0.01 |
| Q1 2026 | -$0.46 | -$0.18 |
| Q4 2025 | -$0.44 | -$0.07 |
| Q3 2025 | -$0.46 | -$0.32 |
| Q2 2025 | -$0.42 | -$0.13 |
| Q1 2025 | -$0.28 | +$0.25 |
| Q4 2024 | -$0.37 | +$0.14 |
CEVA has the edge over ASTS on earnings, with more consistent year-over-year improvement.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over CEVA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
CEVA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $29.1M | +2.4% |
| Q2 2026 | $29M | +13% |
| Q1 2026 | $27M | +11% |
| Q4 2025 | $31.3M | +7.1% |
| Q3 2025 | $28.4M | +4.3% |
| Q2 2025 | $25.7M | -9.7% |
| Q1 2025 | $24.2M | +9.8% |
| Q4 2024 | $29.2M | +21% |
CEVA's revenue has grown year over year for five quarters in a row: $29M last quarter, up 2.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -12% | -4.8 points |
| Q2 2026 | -7.2% | +10 points |
| Q1 2026 | -19% | -0.8 points |
| Q4 2025 | -1.3% | -1.5 points |
| Q3 2025 | -7.3% | +2.3 points |
| Q2 2025 | -17% | -17 points |
| Q1 2025 | -18% | +4.4 points |
| Q4 2024 | 0.3% | +12 points |
CEVA has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
CEVA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $434K | +$6.7M |
| Q2 2026 | $5.2M | +955% |
| Q1 2026 | -$7.2M | +$515K |
| Q4 2025 | $7.2M | +3.1% |
| Q3 2025 | -$6.3M | -$6.3M |
| Q2 2025 | $492K | -72% |
| Q1 2025 | -$7.7M | +$539K |
| Q4 2024 | $7M | +73% |
CEVA has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has the edge over CEVA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
CEVA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.2% | +327K shares |
| 1 year | +18% | +4.4M shares |
| 3 years | +20% | +4.7M shares |
| 5 years | +22% | +5.2M shares |
| Available history | +27% | +6M shares |
CEVA has 28M diluted shares, up 18% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $988,000 |
| Q2 2025 | $6.2M |
| Q1 2025 | — |
| Q4 2024 | $1M |
| Q3 2024 | $4.2M |
| Q2 2024 | $2M |
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CEVA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2022 | -42.2x | Net Cash |
| Q3 2022 | -8.0x | Net Cash |
| Q2 2022 | -2.0x | Net Cash |
| Q1 2022 | -3.5x | Net Cash |
| Q4 2021 | -3.5x | Net Cash |
| Q3 2021 | -3.3x | Net Cash |
| Q2 2021 | -3.2x | Net Cash |
| Q1 2021 | -10.5x | Net Cash |
CEVA has more cash than debt.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
CEVA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.9 | Neutral |
| Stochastic | 25.4 | Neutral |
CEVA's weekly RSI is 43 (neutral) and its Stochastic is 25 (neutral).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
CEVA PE vs Technology Sector
| Metric | CEVA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CEVA has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
CEVA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $30.7 | 14% below |
| 20 week MA | $32.6 | 19% below |
| 50 week MA | $29.4 | 11% below |
| 100 week MA | $27.7 | 4.9% below |
| 200 week MA | $25.7 | 2.3% above |
CEVA has fallen below most of its moving averages, though it's still 2.3% above its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
CEVA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $27.1 | $42.2 | +56% |
| 2021 | $42.2 | $44.4 | +5.1% |
| 2022 | $44.4 | $25.9 | -42% |
| 2023 | $25.9 | $22.7 | -12% |
| 2024 | $22.7 | $32.4 | +43% |
| 2025 | $32.4 | $21.7 | -33% |
| 2026 YTD | $21.7 | $26.3 | +21% |
CEVA has the edge over ASTS on returns for 2026, with the stronger performance.